Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 26/11/2008

    Tetec AG opens new production facility

    On 20th November 2008 Tetec AG opened a new facility for the production of cartilage transplants. The company market leader and a subsidiary of B. Braun Melsungen AG based in Reutlingen is expanding its production capacities.

    https://www.gesundheitsindustrie-bw.de/en/article/news/tetec-ag-opens-new-production-facility
  • Press release - 24/11/2008

    Schölly Fibre Optics in Denzlingen – at the limit of production capacities

    Schölly Fiberoptic GmbH based in the city of Denzlingen in the south of Germany has experienced rapid growth over the last few years with its endoscopic solutions. Over the last five years the company has doubled its revenues to 44 million euros per year.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/schoelly-fibre-optics-in-denzlingen-at-the-limit-of-production-capacities
  • Article - 22/11/2008

    How is the brain capable of recognizing different odours?

    Professor Giovanni Galizia from Constance is investigating the processing of odour cues. Together with other scientists Galizia has initiated a DFG research priority on olfactory processing in humans and animals.

    https://www.gesundheitsindustrie-bw.de/en/article/news/how-is-the-brain-capable-of-recognizing-different-odours
  • Dossier - 20/11/2008 width=

    Anti-Ageing is still a far-off dream

    Is it possible to halt the ageing process? This question was first raised in the 1980s when researchers succeeded in delaying the ageing process in threadworms by modifying a specific gene. Nowadays hundreds of gene mutations are known to prolong the lifespan of yeast fruit flies and mice. Will the human dream of eternal youth eventually become reality? The truth is probably not.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/anti-ageing-is-still-a-far-off-dream
  • Article - 19/11/2008

    Highest level signalling research

    It runs and runs and is extremely successful The SFB 592 established in 2001 and entitled Signalling mechanisms in embryogenesis and organogenesis investigates the biological functions of different signalling pathways. Since its foundation the scientists of the SFB have published many excellent papers in highly renowned journals. Their work has been of such a high standard that the German Research Foundation DFG has decided to fund the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/highest-level-signalling-research
  • Press release - 18/11/2008

    Oxygen radicals alter immune cells

    Researchers from Heidelberg have discovered that certain oxygen compounds are produced in greater quantities in the body due to cancer or inflammation and that this leads to the alteration of a protein that controls the flexibility and adaptability of certain immune cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/oxygen-radicals-alter-immune-cells
  • Article - 16/11/2008

    Looking for a formula to determine biological age

    The Europe-wide MARK-AGE project involving scientists from 14 countries commenced on the 1st April 2008. Scientists have joined forces to investigate the factors involved in ageing. They are using standardised questionnaires and analysing data acquired from physical and biochemical examinations of the blood and urine from 3700 volunteers. The team of experts includes the medical expert Professor Alexander Bürkle and the mathematician Prof.…

    https://www.gesundheitsindustrie-bw.de/en/article/news/looking-for-a-formula-to-determine-biological-age
  • Article - 15/11/2008

    What has mathematics got to do with drugs?

    Prof. Johannes Schropp and Gilbert Koch from the University of Constance are developing mathematical models for the pharmaceutical company Nycomed. These models examine the relationship between the concentration and the effect of administered drugs.

    https://www.gesundheitsindustrie-bw.de/en/article/news/what-has-mathematics-got-to-do-with-drugs
  • Article - 13/11/2008

    Ageing stem cells loose ability to adhere to stroma

    Hartmut Geiger a biochemist and stem cell researcher at Ulm University Hospital is using genetic methods to investigate the molecular basis of the physiological ageing of haematopoietic stem cells. After having spent a period in Cincinnati Geiger is currently head of the clinical research group Molecular and cellular ageing from the mechanisms of action to clinical perspectives.

    https://www.gesundheitsindustrie-bw.de/en/article/news/ageing-stem-cells-loose-ability-to-adhere-to-stroma
  • Article - 03/11/2008

    Hartmann acquires hygiene specialist Bode

    Paul Hartmann AG signed an agreement to acquire Beiersdorf affiliate Bode Chemie GmbH Co. KG. Ownership is expected to transfer at the end of the year. The purchase agreement includes a long-term guarantee for the Hamburg location.

    https://www.gesundheitsindustrie-bw.de/en/article/news/hartmann-acquires-hygiene-specialist-bode
  • Article - 29/10/2008

    Cannabinoids - important for memory?

    Cannabis intoxication is certainly not the original purpose of the cannabinoid receptors in the human brain. Nowadays there are known body substances which dock to the receptor molecules of nerve cells in a similar way to cannabis. A group of researchers led by pharmacologist Prof. Dr. med. Bela Szabo at the University of Freiburg is investigating the role of this molecular system in the human brain.

    https://www.gesundheitsindustrie-bw.de/en/article/news/cannabinoids-important-for-memory
  • Press release - 27/10/2008

    Boost for stem cell research in Heidelberg

    Thanks to the support of the Joachim Siebeneicher Foundation in Heidelberg the University Hospital of Heidelberg has been able to establish an endowed professorship for regenerative medicine. The professorship will start on 1st January 2009.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/boost-for-stem-cell-research-in-heidelberg
  • Article - 23/10/2008

    Fresh wind in BioLAGO's sails

    From informal gatherings to an association and since 1st July 2008 its own office in Constance the BioLAGO life sciences network at Lake Constance hopes that its new premises and organisational remodelling will help in the better and more comprehensive exploitation of the life sciences and biotechnology potential of the entire Lake Constance region.

    https://www.gesundheitsindustrie-bw.de/en/article/news/fresh-wind-in-biolago-s-sails
  • Press release - 17/10/2008

    "Stem cell crazy"

    For three days from 9 to 11 October more than 300 scientists from over 20 countries met at the Haus der Wirtschaft in Stuttgart to discuss the current state of research the latest product developments and therapies in regenerative medicine and stem cell research.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/stem-cell-crazy
  • Press release - 13/10/2008

    Phenex AG closes €8.2 million financing round

    A consortium is providing funding for the development of Phenex drug candidates for type 2 diabetes and metabolic syndrome. Phenex will take its metabolic syndrome drug candidates into Phase I clinical testing by early 2010 at the latest.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/phenex-ag-closes-8-2-million-financing-round
  • Press release - 07/10/2008

    GENEDATA SCREENER® – specialised data analysis for the identification of high-potential lead structures

    Genedata AG has developed a modular software system known as Genedata Screener that is tailored to screening and hit-to-lead applications. Dr. Timo Wittenberg who works at the companys site in Constance Germany told us about the advantages of the software for identifying high-potential leads.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/genedata-screener-specialised-data-analysis-for-the-identification-of-high-potential-lead-structures
  • Press release - 01/10/2008

    Karin Scharffetter-Kochanek: research that gets under the skin

    Prof. Karin Scharffetter-Kochanek has recently become a member of the renowned Leopoldina Academy of Sciences. In her research the skin has become a model system that serves as the basis for a trans-organ systemic approach looking at the underlying mechanisms and the complex interactions with other organs.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/karin-scharffetter-kochanek-research-that-gets-under-the-skin
  • Press release - 28/09/2008

    TNI medical AG - no more sleep-related anxiety

    Sleep-related breathing problems can in the long term even lead to cardiac infarction or stroke. A new technology from TNI medical AG puts a stop to the discomforts of a mask by giving people a seminal solution.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/tni-medical-ag-no-more-sleep-related-anxiety
  • Article - 26/09/2008

    Research cooperation with biotech companies

    Boehringer Ingelheims research cooperation with the two biotech companies Evotec and Orexo is making good progress. Swedish Orexo AB recently announced that it has extended its three-year research cooperation with Boehringer Ingelheim for another year up to November 2009.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/research-cooperation-with-biotech-companies
  • Article - 22/09/2008

    EMEA recommends Orphan Drug Designation for AX200

    SYGNIS Pharma AG announced that it has received a positive recommendation from the Committee for Orphan Medicinal Products of the European Medicines Agency for AX200 in the treatment of spinal cord injury.

    https://www.gesundheitsindustrie-bw.de/en/article/news/emea-recommends-orphan-drug-designation-for-ax200
  • Article - 16/09/2008

    New opportunities for the MedCare TechArea

    Although the MedCare TechArea was not one of the five top clusters to recently receive an award from the German Federal Ministry of Education and Research the cluster and its MedCare TechArea will be further developed.

    https://www.gesundheitsindustrie-bw.de/en/article/news/new-opportunities-for-the-medcare-techarea
  • Article - 10/09/2008

    Patients with rare diseases benefit from European research networks

    In some types of spinocerebellar ataxia and spastic paraplegia the number of people affected is so small that the search for the causes of the disease seems to be an almost hopeless endeavour. Human geneticist Prof. Dr. Olaf Rieß and neurologist Prof. Dr. Ludger Schöls from the University Hospital Tübingen are now hoping to promote research and improve the medical treatment of such patients with the aid of two new European networks.

    https://www.gesundheitsindustrie-bw.de/en/article/news/patients-with-rare-diseases-benefit-from-european-research-networks
  • Article - 08/09/2008

    Research increases hope

    Duchenne muscular dystrophy DMD is a severe disease affecting boys characterised by rapid progression of muscle degeneration so that boys as young as 10 to 12 years of age have to use a wheelchair and leading to death in young men. In Germany about 2500 children and young adults suffer from DMD.

    https://www.gesundheitsindustrie-bw.de/en/article/news/research-increases-hope
  • Article - 02/09/2008

    Screening with high quality and high throughput

    The Early Discovery department of the research-based pharmaceutical company Nycomed GmbH deals with early drug research from the identification of targets to the generation of lead structures. This process involves high-throughput drug screening. On behalf of www.bio-pro.de Michael Statnik talked with Dr. Stefanie Polej about the process of the automated analysis of molecule activities in the Constance-based company.

    https://www.gesundheitsindustrie-bw.de/en/article/news/screening-with-high-quality-and-high-throughput
  • Press release - 28/08/2008

    Günther Schütz and the regulation of gene expression by nuclear receptors

    Professor Dr. Günther Schützs work on the cell- and development-specific gene regulation using nuclear receptors has led amongst other things to new insights into the steroid hormone-dependent early development and differentiation of the nervous system the molecular mechanisms of learning and the development and regulation of drug addiction. Schütz has now been appointed Helmholtz professor which will enable him to continue his work beyond…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/guenther-schuetz-and-the-regulation-of-gene-expression-by-nuclear-receptors

Page 17 / 20

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search